PCL Inc
KOSDAQ:241820
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
PCL Inc
Research & Development
PCL Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
PCL Inc
KOSDAQ:241820
|
Research & Development
-₩962.9m
|
CAGR 3-Years
40%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Research & Development
-₩31.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-12%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Research & Development
-₩16.7B
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Research & Development
-₩1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Research & Development
-₩2.9B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Research & Development
-₩4.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PCL Inc
Glance View
PCL, Inc. engages in the manufacturing of medical devices. The company is headquartered in Seoul, Seoul. The company went IPO on 2017-02-23. The Company’s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.
See Also
What is PCL Inc's Research & Development?
Research & Development
-962.9m
KRW
Based on the financial report for Sep 30, 2025, PCL Inc's Research & Development amounts to -962.9m KRW.
What is PCL Inc's Research & Development growth rate?
Research & Development CAGR 5Y
20%
Over the last year, the Research & Development growth was 41%. The average annual Research & Development growth rates for PCL Inc have been 40% over the past three years , 20% over the past five years .
